- Home
- EVGN vs ADXN Comparison
EVGN vs ADXN Comparison
Compare EVGN & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- ADXN
- Stock Information
- Founded
- EVGN 1999
- ADXN 2002
- Country
- EVGN Israel
- ADXN Switzerland
- Employees
- EVGN N/A
- ADXN N/A
- Industry
- EVGN Agricultural Chemicals
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- ADXN Health Care
- Exchange
- EVGN Nasdaq
- ADXN Nasdaq
- Market Cap
- EVGN 7.3M
- ADXN 8.1M
- IPO Year
- EVGN N/A
- ADXN N/A
- Fundamental
- Price
- EVGN $1.28
- ADXN $9.00
- Analyst Decision
- EVGN Strong Buy
- ADXN Strong Buy
- Analyst Count
- EVGN 1
- ADXN 1
- Target Price
- EVGN $3.50
- ADXN $30.00
- AVG Volume (30 Days)
- EVGN 5.5M
- ADXN 10.6K
- Earning Date
- EVGN 08-21-2025
- ADXN 06-19-2025
- Dividend Yield
- EVGN N/A
- ADXN N/A
- EPS Growth
- EVGN N/A
- ADXN N/A
- EPS
- EVGN N/A
- ADXN 0.10
- Revenue
- EVGN $6,765,000.00
- ADXN $278,508.00
- Revenue This Year
- EVGN N/A
- ADXN $86.57
- Revenue Next Year
- EVGN $113.18
- ADXN N/A
- P/E Ratio
- EVGN N/A
- ADXN $0.72
- Revenue Growth
- EVGN N/A
- ADXN N/A
- 52 Week Low
- EVGN $0.95
- ADXN $6.51
- 52 Week High
- EVGN $7.19
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- EVGN 47.33
- ADXN 55.39
- Support Level
- EVGN $1.34
- ADXN $8.02
- Resistance Level
- EVGN $1.63
- ADXN $9.78
- Average True Range (ATR)
- EVGN 0.16
- ADXN 0.73
- MACD
- EVGN -0.02
- ADXN 0.02
- Stochastic Oscillator
- EVGN 15.56
- ADXN 32.94
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.